Berallo, Jacklyn R.

HRN: 19-94-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/14/2022
09/21/2022
PO
2.3ml On Day 1, Then 1ml Day2-5
OD
Pcap B
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: